[Form 4] Alamar Biosciences, Inc. Insider Trading Activity
Alamar Biosciences President Timothy Ogden White reported equity awards and restructuring of his holdings in connection with the company’s initial public offering.
Rhea-AI Filing Summary
Alamar Biosciences President Timothy Ogden White reported equity awards and restructuring of his holdings in connection with the company’s initial public offering. On April 20, 2026, he received 37,220 shares of Common Stock as restricted stock units that vest monthly, bringing his direct Common Stock holdings to 491,803 shares.
The filing also shows multiple Class B Common Stock and related stock options being reclassified into equivalent Common Stock immediately prior to completion of the IPO, with no cash changing hands. Separately, on April 16, 2026, he was granted a stock option for 163,358 shares of Common Stock at an exercise price of $17.00 per share, vesting over time beginning in 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Stock Option (Right to Buy) | 29,357 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 29,357 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 8,726 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 8,726 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 10,686 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 10,686 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 206,782 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 206,782 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 8,532 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 8,532 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 5,775 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 5,775 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 16,333 | $0.00 | $0.00 |
| Other | Stock Option (Right to Buy) | 16,333 | $0.00 | $0.00 |
| Other | Class B Common Stock | 454,583 | $0.00 | $0.00 |
| Other | Common Stock | 454,583 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 37,220 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 163,358 | $0.00 | $0.00 |
Footnotes (9)
- F1. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
- F2. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.
- F3. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
- F4. Fully vested.
- F5. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date.
- F6. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date.
- F7. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
- F8. Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
- F9. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
Class B Common Stock financial
initial public offering financial
Stock Option (Right to Buy) financial
vesting financial
reclassified financial
AI-generated analysis. How Rhea-AI works. Not financial advice.